• News

    Considering Costs U.S. Hospitals choose Anticoagulant Rivaroxaban Over Warfarin

    March 28, 2016

    NEW YORK (Reuters Health) - U.S. hospitals save money when they use the novel oral anticoagulant rivaroxaban instead of warfarin to treat patients with venous thromboembolism (VTE), a new analysis finds. "These days it's important to consider the cost of new drugs to the health system," Dr.

  • News

    Study Shows ICDs Benefit Women in Heart Failure Prevention

    February 4, 2016

    NEW YORK (Reuters Health)—Women with heart failure (HF) derive as much benefit from implantable cardiac defibrillators (ICDs) for primary prevention as men, according to a comparative effectiveness study. "Randomized clinical trials demonstrated that the ICD confers survival benefit to many patie

  • News

    Elderly Patients with Pneumonia Benefit from ICU Care

    November 18, 2015

    NEW YORK - Elderly patients with pneumonia whose need for intensive care unit (ICU) admission is uncertain actually fare better in the ICU than on the general medical ward, a new study suggests. "Although our results should be confirmed with a randomized trial, clinicians should be aware that man